HighPoint Advisor Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Sell |
8,738
-222
| -2% | -$29.3K | 0.04% | 303 |
|
|
2026
Q1 | $1.25M | Sell |
8,960
-23,112
| -72% | -$3.24M | 0.05% | 252 |
|
|
2025
Q4 | $3.94M | Buy |
32,072
+11,538
| +56% | +$1.4M | 0.09% | 211 |
|
|
2025
Q3 | $2.28M | Buy |
20,534
+1,004
| +5% | +$114K | 0.11% | 147 |
|
|
2025
Q2 | $2.17M | Buy |
19,530
+463
| +2% | +$49.3K | 0.12% | 143 |
|
|
2025
Q1 | $1.99M | Buy |
19,067
+105
| +0.6% | +$10.8K | 0.12% | 143 |
|
|
2024
Q4 | $1.82M | Sell |
18,962
-688
| -4% | -$61.9K | 0.1% | 157 |
|
|
2024
Q3 | $1.76M | Buy |
19,650
+587
| +3% | +$44.8K | 0.1% | 160 |
|
|
2024
Q2 | $1.49M | Sell |
19,063
-149
| -0.8% | -$9.94K | 0.09% | 172 |
|
|
2024
Q1 | $1.3M | Buy |
19,212
+1,394
| +8% | +$107K | 0.09% | 172 |
|
|
2023
Q4 | $1.29M | Buy |
+17,818
| New | +$1.39M | 0.09% | 181 |
|
|
2022
Q2 | $1.01M | Buy |
+16,063
| New | +$995K | 0.11% | 150 |
|
|
2021
Q3 | $993K | Buy |
14,218
+384
| +3% | +$27K | 0.1% | 167 |
|
|
2021
Q2 | $953K | Buy |
13,834
+3,680
| +36% | +$246K | 0.1% | 178 |
|
|
2021
Q1 | $661K | Buy |
10,154
+523
| +5% | +$33.7K | 0.08% | 215 |
|
|
2020
Q4 | $648K | Buy |
+9,631
| New | +$581K | 0.08% | 203 |
|
|
2019
Q4 | – | Sell |
-3,576
| Closed | -$157K | – | 407 |
|
|
2019
Q3 | $157K | Hold |
3,576
| – | – | 0.03% | 357 |
|
|
2019
Q2 | $137K | Sell |
3,576
-8,087
| -69% | -$532K | 0.03% | 378 |
|
|
2019
Q1 | $774K | Sell |
11,663
-348
| -3% | -$23.1K | 0.19% | 110 |
|
|
2018
Q4 | $801K | Sell |
12,011
-91
| -0.8% | -$6.36K | 0.21% | 108 |
|
|
2018
Q3 | $875K | Sell |
12,102
-211
| -2% | -$15.9K | 0.24% | 102 |
|
|
2018
Q2 | $931K | Buy |
12,313
+66
| +0.5% | +$4.66K | 0.25% | 103 |
|
|
2018
Q1 | $881K | Sell |
12,247
-10,584
| -46% | -$841K | 0.24% | 107 |
|
|
2017
Q4 | $1.84M | Buy |
22,831
+2,939
| +15% | +$223K | 0.53% | 47 |
|
|
2017
Q3 | $1.47M | Buy |
19,892
+256
| +1% | +$19.6K | 0.46% | 50 |
|
|
2017
Q2 | $1.44M | Hold |
19,636
| – | – | 0.46% | 50 |
|
|
2017
Q1 | $1.44M | Buy |
19,636
+8,859
| +82% | +$623K | 0.46% | 50 |
|
|
2016
Q4 | $756K | Sell |
10,777
-297
| -3% | -$22.1K | 0.24% | 107 |
|
|
2016
Q3 | $837K | Buy |
11,074
+51
| +0.5% | +$4.14K | 0.29% | 83 |
|
|
2016
Q2 | $874K | Buy |
11,023
+7,322
| +198% | +$650K | 0.31% | 83 |
|
|
2016
Q1 | $337K | Sell |
3,701
-8,692
| -70% | -$784K | 0.21% | 129 |
|
|
2015
Q4 | $1.14M | Sell |
12,393
-4,728
| -28% | -$492K | 0.75% | 31 |
|
|
2015
Q3 | $1.68M | Buy |
17,121
+1,394
| +9% | +$155K | 1.86% | 5 |
|
|
2015
Q2 | $1.84M | Buy |
15,727
+521
| +3% | +$56.9K | 2.84% | 5 |
|
|
2015
Q1 | $1.53M | Buy |
15,206
+4,244
| +39% | +$431K | 2.34% | 10 |
|
|
2014
Q4 | $1.1M | Buy |
+10,962
| New | +$1.13M | 2.03% | 28 |
|
Other funds holding GILD
HighPoint Advisor Group's GILD Position: Q2 2026 in Review
HighPoint Advisor Group reduced its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, selling an estimated $29.3K and leaving 8,738 shares worth $1.1M. The position accounts for 0.04% of the portfolio, ranked #303.
HighPoint Advisor Group first reported a position in GILD in Q4 2014 and has held it in 36 quarters since. The position peaked at $3.94M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- HighPoint Advisor Group held 8,738 shares of Gilead Sciences worth $1.1M as of Q2 2026.
- HighPoint Advisor Group sold 222 Gilead Sciences shares in Q2 2026, an estimated $29.3K.
- Gilead Sciences made up 0.04% of HighPoint Advisor Group's portfolio in Q2 2026, its #303 holding.
- HighPoint Advisor Group first reported a position in Gilead Sciences in Q4 2014 and has held it in 36 quarters since.
- HighPoint Advisor Group's Gilead Sciences position peaked at $3.94M in Q4 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.